Diagnosis and management of congenital dyserythropoietic anemias
Related Experiment Video
Updated: Mar 29, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Antonella Gambale1,2, Achille Iolascon1,2, Immacolata Andolfo1,2
1a Dipartimento di Medicina Molecolare e Biotecnologie Mediche , Università degli Studi di Napoli Federico II , Napoli , Italy.
Insights
Congenital dyserythropoietic anemias (CDAs) are inherited bone marrow failure syndromes causing chronic anemia and iron overload. Accurate diagnosis is crucial for patient management due to potential misdiagnosis with other anemias.
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Background:
- Congenital dyserythropoietic anemias (CDAs) are rare inherited bone marrow failure syndromes.
- Characterized by chronic hyporegenerative anemia, reticulocytopenia, hemolysis, and iron overload.
- Impaired erythroid lineage differentiation and proliferation are key features.
Purpose of the Study:
- To review the classification and pathomechanisms of CDAs.
- To highlight the diagnostic challenges and importance of differential diagnosis.
- To emphasize the need for accurate diagnosis for patient management.
Main Methods:
- Review of existing literature on CDAs.
- Analysis of classification systems from classical morphology to genetic types.
- Discussion of pathomechanisms involving DNA replication and cell division.
Main Results:
- CDAs encompass at least six genetic types, expanding beyond three classical morphological classifications.
- Diverse pathomechanisms converge on the regulation of DNA replication and cell division.
- High potential for misdiagnosis with other anemias due to overlapping features.
Conclusions:
- Accurate differential diagnosis of CDAs is critical.
- Proper diagnosis guides patient follow-up and therapeutic strategies.
- Understanding genetic heterogeneity is key to advancing CDA research and treatment.
Abstract:
Congenital dyserythropoietic anemias (CDAs) are inherited disorders hallmarked by chronic hyporegenerative anemia, relative reticulocytopenia, hemolytic component and iron overload. They represent a subtype of the inherited bone marrow failure syndromes, characterized by impaired differentiation and proliferation of the erythroid lineage. Three classical types were defined by marrow morphology, even if the most recent classification recognized six different genetic types. The pathomechanisms of CDAs are different, but all seem to involve the regulation of DNA replication and cell division. CDAs are often misdiagnosed, since either morphological abnormalities or clinical features can be commonly identified in other clinically-related anemias. However, differential diagnosis is essential for guiding both follow up and management of the patients.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
08:53Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
Published on: January 10, 2025
Related Concept Videos
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythropoiesis
Erythropoiesis
Rh Blood Group
Dysrhythmias VII: Nursing Management of Dysrhythmias
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...